- Home
- VS vs NCNA Comparison
VS vs NCNA Comparison
Compare VS & NCNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | VS | NCNA |
|---|---|---|
| Founded | 2013 | 1997 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | EDP Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.4M | 7.6M |
| IPO Year | N/A | 2017 |
Fundamental Metrics
Financial Performance| Metric | VS | NCNA |
|---|---|---|
| Price | $1.19 | $3.80 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 87.7K | 65.1K |
| Earning Date | 11-14-2025 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $2,179,348.00 | N/A |
| Revenue This Year | $3,459.21 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 2281.70 | N/A |
| 52 Week Low | $1.15 | $2.78 |
| 52 Week High | $3.79 | $330.00 |
Technical Indicators
Market Signals| Indicator | VS | NCNA |
|---|---|---|
| Relative Strength Index (RSI) | 32.94 | 43.41 |
| Support Level | $1.20 | $4.10 |
| Resistance Level | $1.47 | $4.55 |
| Average True Range (ATR) | 0.10 | 0.28 |
| MACD | 0.00 | -0.01 |
| Stochastic Oscillator | 18.41 | 0.00 |
Price Performance
Historical ComparisonAbout VS Versus Systems Inc.
Versus Systems Inc offers a suite of proprietary business-to-business software tools that are meant to drive user engagement through gamification and rewards. These tools allow its partners to offer in-game prizes and rewards, including merchandise, coupons, digital goods, and sweepstakes entries - inside their websites, their venues, or their streaming media content. Its customers are mostly sports teams, venues, and advertising agencies, which typically use its products as part of their live events or as part of an advertising campaign with the goal of engaging fans, increasing consented first-party data, and increasing sales. The company operates in Canada and the USA.
About NCNA NuCana plc
NuCana PLC is a biopharmaceutical company focused on improving treatment outcomes for cancer patients by ProTide technology. Utilizing proprietary ProTide technology, the firm is developing new medicines designed to overcome key cancer resistance mechanisms and generate much higher concentrations of anti-cancer metabolites in cancer cells. The company's ProTide pipeline products are NUC-3373, NUC-7738, Acelarin. Geographically operates through the region of the United States.